Back
Amicus Therapeutics, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
66
FOLD
Amicus Therapeutics, Inc.
Last Price:
$10.91
Seasonality Move:
4.76%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAmicus Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Amicus Therapeutics, Inc. has on average historically risen by 22.4% based on the past 18 years of stock performance.
-
Amicus Therapeutics, Inc. has risen higher in 9 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Amicus Therapeutics, Inc. Stock Undervalued?The current Amicus Therapeutics, Inc. [FOLD] share price is $11.00. The Score for FOLD is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
FOLD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Amicus Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Amicus Therapeutics, Inc. has on average historically risen by 22.4% based on the past 18 years of stock performance.
Amicus Therapeutics, Inc. Stock Rating
Buy
66
Amicus Therapeutics, Inc. (FOLD)
is a Buy
Is Amicus Therapeutics, Inc. overpriced?
-
Amicus Therapeutics, Inc. has risen higher in 9 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Amicus Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com
52-Week Data
52-Week High:
11.14
52-Week Low:
5.51
Prediction Charts
Market Cap:
3.4B
Price in USD:
11.00
Volume:
6.3M
Beta:
0.98
Technical Analysis
SMA50:
9.27
SMA100:
8.43
SMA200:
7.64
52-Wk Change:
11.22%
Stock Predictions
-
Is Amicus Therapeutics, Inc. stock public?Yes, Amicus Therapeutics, Inc. is a publicly traded company.
-
What is the Amicus Therapeutics, Inc. stock quote today?The Amicus Therapeutics, Inc. stock price is 11.00 USD today.
-
How to buy Amicus Therapeutics, Inc. stock online?You can buy Amicus Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-28 | 9.99 | 9.93 | 10.05 | 9.88 |
| Dec-1 | 9.92 | 9.80 | 10.05 | 9.77 |
| Dec-2 | 9.87 | 9.73 | 10.02 | 9.56 |
| Dec-3 | 9.78 | 9.78 | 9.85 | 9.66 |
| Dec-4 | 9.67 | 9.95 | 9.99 | 9.63 |
| Dec-5 | 9.96 | 9.90 | 10.05 | 9.79 |
| Dec-8 | 10.03 | 9.85 | 10.03 | 9.73 |
| Dec-9 | 9.85 | 9.81 | 9.94 | 9.79 |
| Dec-10 | 9.78 | 9.85 | 9.91 | 9.73 |
| Dec-11 | 9.84 | 9.90 | 9.97 | 9.74 |
| Dec-12 | 9.92 | 10.55 | 11.00 | 9.78 |
| Dec-15 | 10.54 | 10.88 | 11.14 | 10.50 |
| Dec-16 | 10.80 | 10.89 | 11.09 | 10.75 |
| Dec-17 | 10.94 | 11.00 | 11.14 | 10.91 |
Amicus Therapeutics, Inc. Earnings
Amicus Therapeutics, Inc. Earnings Report: Per Share Amicus Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amicus Therapeutics, Inc. Forecast Revenue Growth
Amicus Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.28 per share.
* Amicus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.